Jefferies Reiterates a 'Hold' on Metabolix (MBLX); Uncertainty Despite PHA Partner

Jefferies reiterates a 'Hold' on Metabolix (NASDAQ: MBLX) price target of $2.20 (from $3.15).

Analyst, Laurence Alexander, said, "We expect the technology value of Metabolix's PHA IP to continue to be masked by uncertainty as to what economics it may be able to capture on manufacturing partnerships, as well as whether a step up in its cash burn will be required to move biochemical partnerships to commercialization."

For an analyst ratings summary and ratings history on Metabolix click here. For more ratings news on Metabolix click here.

Shares of Metabolix closed at $1.81 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
• Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities